About Burning Rock Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to guard life via science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of: 1) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 273,000 tissue and liquid-based tests completed cumulatively. 2) cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage. In July 2018, Burning Rock received the first approval for a tumor NGS kit by the National Medical Products Administration (NMPA), which is a significant milestone in the field of in vitro diagnosis in China. Burning Rock’s laboratory has obtained the technical certification of “High-throughput sequencing laboratory” issued by Guangdong Center for Clinical Laboratory, and the CLIA and CAP laboratory quality system certification. The company continues to be committed to the development of innovative and reliable NGS testing products and promoting the development of precision medicine in oncology. 燃石医学(纳斯达克代码:BNR)成立于2014年,公司使命为“用科学守护生命之光”,专注于为肿瘤精准医疗提供具有临床价值的二代基因测序(NGS)。公司业务及研发方向主要覆盖: 1)基于NGS的肿瘤患病人群检测,累计检测样本超过27万例,在中国拥有领先的市场份额; 2)基于NGS的癌症早检,目前已经进入临床验证阶段。 燃石医学于2018年7月获国家药品监督管理局(NMPA)颁发的中国肿瘤NGS检测试剂盒第一证,在体外诊断领域具有里程碑式意义。位于中国广州的实验室通过广东省临检中心颁发的“高通量测序实验室”技术审核,获得美国CLIA和CAP实验室质量体系资质认证;位于美国加利福尼亚州的实验室也已获得CLIA和CAP实验室质量体系资质认证。公司将继续致力于开发创新可靠的NGS检测产品,推动肿瘤精准医疗领域的发展。
View Top Employees from 燃石医学 Burning Rock BiotechWebsite | http://www.brbiotech.com/ |
Ticker | BNR |
Revenue | $56 million |
Funding | $304.2 million |
Employees | 187 (105 on RocketReach) |
Founded | 2014 |
Address | No. 5 Xingdao Ring Road North International Bio Is, Guangzhou, Guangdong 510005, CN |
Phone | +86 185 0164 1666 |
Industry | Biotechnology Research, Medical Testing & Clinical Laboratories, Healthcare |
Keywords | Cancer Research, Molecular Diagnostics |
Competitors | ArcherDX, Inc., Guardant Health, Lengo Therapeutics, PharmaMar, 北京诺禾致源科技股份有限公司 |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular 燃石医学 Burning Rock Biotech employee's phone or email?
The 燃石医学 Burning Rock Biotech annual revenue was $56 million in 2024.
Yusheng Han is the CEO of 燃石医学 Burning Rock Biotech.
105 people are employed at 燃石医学 Burning Rock Biotech.
燃石医学 Burning Rock Biotech is based in Guangzhou, Guangdong.
The NAICS codes for 燃石医学 Burning Rock Biotech are [541713, 54171, 54, 541, 5417].
The SIC codes for 燃石医学 Burning Rock Biotech are [87, 873].